Probenecid Inhibits SARS-CoV-2 Replication In Vivo and In Vitro
J. Murray, R. J. Hogan, D. E. Martin, K. Blahunka, F. Sancillo, R. Balyan, M. Lovern, R. Still, R. A. Tripp
This study shows probenecid inhibits SARS-CoV-2 replication in mammalian cells and a hamster model, with achievable plasma concentrations supporting its potential clinical use.
bioRxiv · May 21, 2021Microbiology